about
A systematic review of the cardiotoxicity of methadoneFetal heart rate and motor activity associations with maternal organochlorine levels: results of an exploratory studyThe gestational foundation of sex differences in development and vulnerabilitySTUDIES IN FETAL BEHAVIOR: REVISITED, RENEWED, AND REIMAGINED.The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data.Gender issues in the pharmacotherapy of opioid-addicted women: buprenorphine.Infant autonomic functioning and neonatal abstinence syndromeFetal neurobehavioral effects of exposure to methadone or buprenorphine.Pregnancies exposed to methadone, methadone and other illicit substances, and poly-drugs without methadone: a comparison of fetal neurobehaviors and infant outcomesMaternal stress in pregnancy: considerations for fetal development.Fetal heart rate and variability: stability and prediction to developmental outcomes in early childhood.A Multidisciplinary Approach to the Treatment of Co-occurring Opioid Use Disorder and Posttraumatic Stress Disorder in Pregnancy: A Case Report.Pregnancy and injecting drug use.Treatment of opioid-dependent pregnant women: clinical and research issues.Maternal methadone dosing schedule and fetal neurobehaviour.The opioid-exposed newborn: assessment and pharmacologic management.Prenatal methadone exposure and neonatal neurobehavioral functioning.Methadone and buprenorphine for the management of opioid dependence in pregnancy.When one drug affects 2 patients: a review of medication for the management of nonlabor-related pain, sedation, infection, and hypertension in the hospitalized pregnant patient.Pharmacological Management of Opioid Use Disorder in Pregnant Women.Maternal buprenorphine treatment and fetal neurobehavioral development.The relationship between maternal opiate use, amphetamine use and smoking on fetal growth.Maternal vagal tone change in response to methadone is associated with neonatal abstinence syndrome severity in exposed neonates.
P2860
Q26766513-3D2734B0-374F-4F40-97E1-45703DA6AA36Q28384289-46DC0B8F-CF4F-46CB-A56C-6D48653FE0C0Q28385369-9EBEF33D-4413-4A1D-971C-635C2EE3C092Q30375420-2213FA69-7B0A-4F61-A564-074B4F3391EFQ30490602-FE0347A1-B7D1-439E-8A2B-05B64E96CB57Q33807411-547BF762-94AC-4D56-B6F0-B3DE67040E6EQ33872350-5BB25668-FC1D-42D8-8C5A-48F72C203B0CQ34581552-F04FECA9-2FE1-4E0E-805C-E16FB9890600Q35783426-202CF469-C33C-4CF0-86D5-28D5895A54ACQ36108929-F12A2C0D-AE1A-4543-A836-14CB45EDF088Q36496371-F03989FB-8180-452A-A96C-D039F2DCC56CQ36603506-FDFD5733-EB23-4F3D-93D5-106C1725A080Q36700709-A2304882-E494-4548-861D-8CDE0AFCD28FQ37076673-35AE56DA-97A2-4B09-A546-AA8005B4720CQ37275955-39FA1CA6-DC7C-40F6-B205-260CF876E7F7Q37310917-166F96FB-69DD-44B3-AC69-ED3B3D189C4CQ37485057-3AED898F-34BB-428C-BB43-6135E72FF9A8Q38003398-3C0B1E37-1227-4A03-8D23-CDA8A130D7F5Q38006442-F2456DE0-975D-47E4-A32B-1358A8123C2AQ38575591-58ADAB26-A9FF-4B76-B6D3-31A7E49E8B1EQ38966232-61E6A2F8-7AAB-4280-B68F-CB8310D06FF5Q44259445-89EF3D73-5715-4C72-89AE-2DD13856AD5DQ54352564-DEFE6759-3692-472D-BB45-0A0AE3B99D35
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Fetal response to maternal methadone administration.
@en
Fetal response to maternal methadone administration.
@nl
type
label
Fetal response to maternal methadone administration.
@en
Fetal response to maternal methadone administration.
@nl
prefLabel
Fetal response to maternal methadone administration.
@en
Fetal response to maternal methadone administration.
@nl
P2093
P1476
Fetal response to maternal methadone administration.
@en
P2093
Andrea Elko
Janet Dipietro
Lauren M Jansson
P304
P356
10.1016/J.AJOG.2005.02.075
P407
P433
P577
2005-09-01T00:00:00Z